Fig. 3From: Predictors of the utility of clinical exome sequencing as a first-tier genetic test in patients with Mendelian phenotypes: results from a referral center study on 603 consecutive casesDiagnostic yield of CES according to the suspected diagnosis when only pathogenic or likely pathogenic (P/LP) variants were considered (Panel A) or when variants of uncertain significance (VUS) were included in the diagnostic yield analysis (Panel B). Vertical bars denote truncated 95% confidence intervals at the right or the left marginBack to article page